Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

NASH Contender Inventiva Backed By Euronext IPO

Executive Summary

The five-year-old French biotech Inventiva Pharma has raised financing on the public markets to propel its lead fibrosis/NASH product through the development pipeline.

Advertisement

Related Content

Intercept Increases Chance Of Success In NASH Without Significant Delay
Deal Watch: Arbor Betting On Building Horizant Commercially As Xenoport Couldn't

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register